Pharmaceutical Industry Rolls Back Dr. Speaker Fees

The pharmaceutical industry seems to be spending less on speaker fees, but it hasn’t stopped influencing doctors and other medical personnel.

Frederick Reese
By Frederick Reese
A new investigation revealed that the FDA is using a variety of tactics to sway public opinion of certain products (AP Photo).

In 2012, GlaxoSmithKline, the world’s fourth-largest pharmaceutical company, pleaded guilty to criminal charges in the single-largest case of health care fraud in American history. Accused of bribing doctors, promoting its medications for unapproved uses and failing to report safety data, the British firm agreed to pay $3 billion in fines,

Read Full Article

GlaxoSmithKline To Quit Paying Doctors For Promotional Talks

The company will no longer hire doctors to promote its drugs and will stop tying drug rep pay to number of prescriptions written.

Charles Ornstein
By Charles Ornstein

In a major departure from industry practice, GlaxoSmithKline, the sixth-largest global drug maker, announced Tuesday that it will no longer hire doctors to promote its drugs. The company also will stop tying compensation for sales representatives to the number of prescriptions written for drugs they market. The changes will be made worldwide

Read Full Article